Off-Label Drug Use for Cancer Therapy and National Health Care Priorities

dc.creator	Moertel, Charles G.	en
dc.date.accessioned	2016-01-08T19:38:11Z	en
dc.date.available	2016-01-08T19:38:11Z	en
dc.date.created	1991-12-04	en
dc.date.issued	1991-12-04	en
dc.identifier.bibliographicCitation	JAMA: The Journal of the American Medical Association 1991 December 4; 266(21): 3031-3032	en
dc.identifier.uri	http://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Off-Label+Drug+Use+for+Cancer+Therapy+and+National+Health+Care+Priorities&title=JAMA:+The+Journal+of+the+American+Medical+Association+&volume=266&issue=21&spage=3031-3032&date=1991-12&au=Moertel,+Charles+G.	en
dc.identifier.uri	http://hdl.handle.net/10822/851136	en
dc.format	Article	en
dc.language	en	en
dc.source	eweb:112361	en
dc.subject	Cancer	en
dc.subject	Health	en
dc.subject	Health Care	en
dc.subject.classification	Drugs and Drug Industry	en
dc.subject.classification	Health Care for Particular Diseases or Groups	en
dc.title	Off-Label Drug Use for Cancer Therapy and National Health Care Priorities	en
dc.provenance	Citation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.	en
dc.provenance	Citation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.	en

Related items